Order Article Reprints

Pons L, Hernández L, Urbizu A, Osorio P, Rodríguez-Martínez P, Castella E, Muñoz A, Sanz C, Arnaldo L, Felip E, et al. Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer. Cancers. 2023; 15(12):3068. https://doi.org/10.3390/cancers15123068

Pons, Laura, Laura Hernández, Aintzane Urbizu, Paula Osorio, Paula Rodríguez-Martínez, Eva Castella, Ana Muñoz, Carolina Sanz, Laura Arnaldo, Eudald Felip, and et al. 2023. "Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer" Cancers 15, no. 12: 3068. https://doi.org/10.3390/cancers15123068

Pons, L., Hernández, L., Urbizu, A., Osorio, P., Rodríguez-Martínez, P., Castella, E., Muñoz, A., Sanz, C., Arnaldo, L., Felip, E., Quiroga, V., Tapia, G., Margelí, M., & Fernandez, P. L. (2023). Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer. Cancers, 15(12), 3068. https://doi.org/10.3390/cancers15123068